June Bray

Director at Quince Therapeutics

Capital raised by Quince Therapeutics

$114.7M+$114.7M latest round

2 Form D filings · first filed May 2026 · South San Francisco, CA

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 2
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: —

Career

1 company on file

Quince TherapeuticsBiotech · South San Francisco, CAsince May 2026

Director

Listed on Quince Therapeutics's Form D filings

Company filings

via EDGAR · Form D for Quince Therapeutics2

DateCompanyFormAmountRole on filing

May 18, 2026Quince TherapeuticsForm D+$114.7M—

Form DMay 18, 2026 · Quince Therapeutics+$114.7Mnot a signer

May 18, 2026Quince TherapeuticsForm D——

Form DMay 18, 2026 · Quince Therapeutics—not a signer

Overview

Last filing May 18, 2026

June Bray is on file as Director at Quince Therapeutics in South San Francisco, CA. Quince Therapeutics has 2 Form D filings on record, $114.7M raised in total.

Teammates

Quince Therapeutics · 1

Dirk ThyeChief Executive OfficerSigner

Products

Quince Therapeutics · 1

eDSPClinical-stage therapeutic

Dexamethasone sodium phosphate encapsulated in a patient's own red blood cells using the AIDE platform, administered as a drug-device combination therapy.